Dengue Vaccine, Challenges, Development and Strategies

Dewi Marbawati • Tri Wijayanti
Journal article None • June 2014 Indonesia

Download full text
(Bahasa Indonesia, 8 pages)


Dengue fever is endemic in more than 100 countries in the world. The effective dengue antiviral drug has not been found yet,and vector control is considered less effective. Prevention program by vaccination is needed. An ideal dengue vaccine shouldbe inexpensive, covering four serotypes (tetravalent), effective in providing immunity, given once a lifetime, safe, stable instorage and genetically. Several vaccine candidates have been and are being developed included attenuated tetravalentvaccine, ChimeriVax, sub- unit vaccines and DNA vaccines. Dengue vaccine is seen as an effective and sustainable approachto controll Dengue infection. In 2003, Pediatric Dengue Vaccine Initiative (PDVI) has been formed as an Internationalconsortium involved in advocacy to convince the International community about the essence and urgency of Dengue vaccine.Indonesian Dengue vaccine consortium is currently working to develop a Dengue vaccine using locally virus strain.





BALABA is a peer-reviewed scientific journal that publishes original research and literature revi... see more